Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor

Abstract

The ets-related gene erg encodes a transcription factor that is implicated in the control of cell growth and differentiation. To identify interacting partners of ERG, we screened a yeast two-hybrid cDNA library constructed from mouse hematopoietic cells using the N-terminal region of ERG as a bait. We isolated a 4.6 kb full-length mouse cDNA encoding a 1307-amino acid protein migrating as a 180 kD band, which was termed ESET (ERG-associated protein with SET domain). ESET is 92% identical to the human protein SETDB1 (SET domain, bifurcated 1). The interaction between ESET and ERG was supported by in vitro pull-down using glutathione S-transferase (GST) fusion protein, by transfection and co-immunoprecipitation experiments, and by association of endogenous SETDB1 with ERG. Since ESET possesses evolutionarily conserved SET, preSET, and postSET domains implicated in histone methylation, we tested the ability of ESET to methylate core histones. The results of these studies demonstrated that ESET is a histone H3-specific methyltransferase, and that mutations within ESET abolished its methyltransferase activity. Together, these findings raise the possibility that transcription factor ERG may participate in transcriptional regulation through ESET-mediated histone methylation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Aletta JM, Cimato TR, Ettinger MJ . 1998 Trends Biochem. Sci. 23: 89–91

  • Bird AP, Wolffe AP . 1999 Cell 99: 451–454

  • Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC, Kouzarides T . 2001 Nature 410: 120–124

  • Buhler D, Raker V, Luhrmann R, Fischer U . 1999 Hum. Mol. Genet. 8: 2351–2357

  • Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW, Stallcup MR . 1999 Science 284: 2174–2177

  • Dunn T, Praissman L, Hagag N, Viola MV . 1994 Cancer Genet Cytogenet. 76: 19–22

  • Giovannini M, Biegel JA, Serra M, Wang JY, Wei YH, Nycum L, Emanuel BS, Evans GA . 1994 J. Clin. Invest. 94: 489–496

  • Hahn SL, Wasylyk B, Criqui-Filipe P, Criqui P . 1997 Oncogene 15: 1489–1495

  • Harte PJ, Wu W, Carrasquillo MM, Matera AG . 1999 Cytogenet. Cell. Genet. 84: 83–86

  • Ichikawa H, Shimizu K, Hayashi Y, Ohki M . 1994 Cancer Res. 54: 2865–2868

  • Im YH, Kim HT, Lee C, Poulin D, Welford S, Sorensen PH, Denny CT, Kim SJ . 2000 Cancer Res. 60: 1536–1540

  • Kozak M . 1991 J. Biol. Chem. 266: 19867–19870

  • Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T . 2001 Nature 410: 116–120

  • Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C, Stehelin D . 1983 Nature 306: 395–397

  • Li R, Pei H, Watson DK . 2000 Oncogene 19: 6514–6523

  • Nomura N, Nagase T, Miyajima N, Sazuka T, Tanaka A, Sato S, Seki N, Kawarabayasi Y, Ishikawa K, Tabata S . 1994 DNA Res. 1: 223–229

  • Nunn MF, Seeburg PH, Moscovici C, Duesberg PH . 1983 Nature 306: 391–395

  • Ponting CP . 1997 Trends Biochem. Sci. 22: 51–52

  • Prasad DD, Ouchida M, Lee L, Rao VN, Reddy ES . 1994 Oncogene 9: 3717–3729

  • Rao VN, Papas TS, Reddy ES . 1987 Science 237: 635–639

  • Raouf A, Seth A . 2000 Oncogene 19: 6455–6463

  • Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M, Opravil S, Mechtler K, Ponting CP, Allis CD, Jenuwein T . 2000 Nature 406: 593–599

  • Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT . 1994 Nat. Genet. 6: 146–151

  • Strahl BD, Allis CD . 2000 Nature 403: 41–45

  • Tachibana M, Sugimoto K, Fukushima T, Shinkai Y . 2001 J. Biol. Chem. 20: 20–

  • Trojanowska M . 2000 Oncogene 19: 6464–6471

  • Tschiersch B, Hofmann A, Krauss V, Dorn R, Korge G, Reuter G . 1994 EMBO J. 13: 3822–3831

  • Wu DY, Kalpana GV, Goff SP, Schubach WH . 1996 J. Virol. 70: 6020–6028

  • Yang L, Embree LJ, Hickstein DD . 2000 Mol. Cell. Biol. 20: 3345–3354

  • Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C . 1993 EMBO J. 12: 4481–4487

Download references

Acknowledgements

We thank Dr Thomas Jenuwein for the myc-SUV39h1 plasmid. This work is supported in part by funds from the Department of Orthopedics and Sports Medicine at the University of Washington and by a New Investigator Grant from the Leukemia Research Foundation (to L Yang). Y Zhang is a V-foundation scholar and work in his lab is supported by NIH (GM63067-01) and ACS (RSG-00-351-01-GMC).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yi Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, L., Xia, L., Wu, D. et al. Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor. Oncogene 21, 148–152 (2002). https://doi.org/10.1038/sj.onc.1204998

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204998

Keywords

This article is cited by

Search

Quick links